ABSTRACT
Introduction: Vitiligo is a chronic skin disorder caused by destruction of the skin melanocytes, which presents as a depigmented area in the skin. This study examined the effect of Phototherapy plus oral Silybummarianum on the treatment of skin lesions of Vitiligo.Materials and methods: In this randomized controlled clinical trial, 34 patients with vitiligo who were referred to Dermatology Clinic of Shahid Faghihi Hospital, Shiraz, Iran, were randomly divided into two groups. The first group was treated with phototherapy plus Narrowband UVB plus oral silymarin and the other group was treated with phototherapy with placebo. The patients in both groups were evaluated with vitiligo area severity index (VASI) at the beginning and end of the study. SPSS software version 23 was used for statistical analyses.Results: The mean of the VASI score showed a statistically significant decrease in both groups at the end of the study (p < .05), but the decrease in the VASI score in patients who received Silybum marianum was more in comparison with the other group.Conclusion: This study showed that probably Silybum marianum is a good choice for patients with vitiligo; however, further studies are recommended to be conducted to confirm our result.
Subject(s)
Antioxidants/therapeutic use , Silymarin/therapeutic use , Vitiligo/therapy , Administration, Oral , Adolescent , Adult , Aged , Double-Blind Method , Female , Humans , Iran , Male , Middle Aged , Phototherapy , Severity of Illness Index , Skin/pathology , Ultraviolet Rays , Vitiligo/drug therapy , Vitiligo/pathology , Young AdultABSTRACT
Eosinophilic pustular folliculitis (EPF) is a recurrent inflammatory dermatosis primarily involving hair follicles. Several subtypes of EPF have been described: Classic EPF, infantile EPF, and immunosuppression-associated EPF. Although classic EPF has a predilection for face, involvement of hairless areas such as palms and soles has been reported frequently. There are rare case reports of mucosal EPF. Herein, we report a woman who presented with classic EPF involving the lip and oral mucosa.
Subject(s)
Eosinophilia/pathology , Facial Dermatoses/pathology , Folliculitis/pathology , Lip Diseases/pathology , Skin Diseases, Vesiculobullous/pathology , Adult , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Chin , Eosinophilia/diagnosis , Eosinophilia/drug therapy , Facial Dermatoses/diagnosis , Facial Dermatoses/drug therapy , Female , Folliculitis/diagnosis , Folliculitis/drug therapy , Humans , Indomethacin/therapeutic use , Lip Diseases/diagnosis , Lip Diseases/drug therapy , Mouth Diseases/diagnosis , Mouth Diseases/drug therapy , Mouth Diseases/pathology , Mouth Mucosa/pathology , Skin Diseases, Vesiculobullous/diagnosis , Skin Diseases, Vesiculobullous/drug therapyABSTRACT
Cutaneous leishmaniasis (CL) is one of the most common endemic diseases in Iran. It has a diverse spectrum of clinical manifestations. Herein we present a woman with leishmanial dactylitis, which is a very rare clinical form of CL. Successful treatment consisted of parenteral pentavalent antimonials for two months. Leishmanial dactylitis can be easily misdiagnosed as bacterial or fungal infections, psoriasis, or even malignancies. Accordingly, it should be considered in the differential diagnosis of dactylitis in endemic areas and in travelers from endemic countries.